Cytogam

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 49591-532
  • Package NDC 49591-532-51
  • Application number BLA103189
  • SPL ID 59d63ee0-9e77-824d-e063-6394a90ae055
  • SPL set ID c8e2bb3f-2a4d-4c55-b145-ba96c1928d44
  • UNII 129L90A25N
  • RxCUI 204528
  • RxCUI 209029

What the source publishes

Labeler
Kamada Ltd.
Active ingredients
HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN
Form
LIQUID
Routes
INTRAVENOUS
Administrative status
present-in-source-snapshot
Marketing status
BLA
Product type
PLASMA DERIVATIVE

Names this record is found by

Complete source data
us:fda:ndc:49591-532_59d63ee0-9e77-824d-e063-6394a90ae055
{
  "name": "Cytogam",
  "splId": "59d63ee0-9e77-824d-e063-6394a90ae055",
  "labels": [
    {
      "setId": "c8e2bb3f-2a4d-4c55-b145-ba96c1928d44",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c8e2bb3f-2a4d-4c55-b145-ba96c1928d44",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c8e2bb3f-2a4d-4c55-b145-ba96c1928d44"
    }
  ],
  "routes": [
    "INTRAVENOUS"
  ],
  "labeler": "Kamada Ltd.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "1 VIAL, GLASS in 1 CARTON (49591-532-51)  / 50 mL in 1 VIAL, GLASS (49591-532-50)",
      "package_ndc": "49591-532-51",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20230601"
    }
  ],
  "productId": "49591-532_59d63ee0-9e77-824d-e063-6394a90ae055",
  "useDomain": "unknown",
  "dosageForm": "LIQUID",
  "productNdc": "49591-532",
  "deaSchedule": null,
  "genericName": "HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN",
  "productType": "PLASMA DERIVATIVE",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN",
      "strength": "2500 mg/50mL"
    }
  ],
  "applicationNumber": "BLA103189",
  "marketingCategory": "BLA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20230601",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "unknown",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000184165",
      "N0000183365",
      "N0000184009",
      "N0000184152",
      "M0011122"
    ],
    "unii": [
      "129L90A25N"
    ],
    "rxcui": [
      "204528",
      "209029"
    ],
    "spl_set_id": [
      "c8e2bb3f-2a4d-4c55-b145-ba96c1928d44"
    ],
    "pharm_class_cs": [
      "Immunoglobulins [CS]"
    ],
    "pharm_class_pe": [
      "Passively Acquired Immunity [PE]"
    ],
    "pharm_class_epc": [
      "Human Immunoglobulin G [EPC]"
    ],
    "pharm_class_moa": [
      "Virus Neutralization [MoA]"
    ],
    "manufacturer_name": [
      "Kamada Ltd."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:49591-532_59d63ee0-9e77-824d-e063-6394a90ae055"